Cargando…

EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial

BACKGROUND: The potential interest of antifungal treatment of non-immunocompromized patients with sepsis, extra-digestive Candida colonization and multiple organ failure is unknown. It represents three-quarters of antifungals prescribed in Intensive Care Units. It may allow early treatment of invasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Timsit, Jean-François, Azoulay, Elie, Cornet, Muriel, Gangneux, Jean-Pierre, Jullien, Vincent, Vésin, Aurélien, Schir, Edith, Wolff, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222830/ https://www.ncbi.nlm.nih.gov/pubmed/24261608 http://dx.doi.org/10.1186/1745-6215-14-399

Ejemplares similares

Performance of Repeated Measures of (1–3)-β-D-Glucan, Mannan Antigen, and Antimannan Antibodies for the Diagnosis of Invasive Candidiasis in ICU Patients: A Preplanned Ancillary Analysis of the EMPIRICUS Randomized Clinical Trial
por: Dupuis, Claire, et al.
Publicado: (2021)

Sextus Empiricus
Publicado: (1949)

Clinical Impact of Antifungal Susceptibility, Biofilm Formation and Mannoside Expression of Candida Yeasts on the Outcome of Invasive Candidiasis in ICU: An Ancillary Study on the Prospective AmarCAND2 Cohort
por: Gangneux, Jean-Pierre, et al.
Publicado: (2018)

Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin
por: Shirazi, Fazal, et al.
Publicado: (2015)

Mortality associated with timing of admission to and discharge from ICU: a retrospective cohort study
por: Laupland, Kevin B, et al.
Publicado: (2011)

Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis
por: Gil-Alonso, Sandra, et al.
Publicado: (2015)

Glutathione Metabolism in Candida albicans Resistant Strains to Fluconazole and Micafungin
por: Maras, Bruno, et al.
Publicado: (2014)

Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patients
por: Timsit, Jean-François, et al.
Publicado: (2015)

Outcome of ICU patients with Clostridium difficile infection
por: Zahar, Jean-Ralph, et al.
Publicado: (2012)

Successful treatment of Candida tropicalis osteomyelitis with Micafungin in a leukemia patient
por: Ma, Liya, et al.
Publicado: (2016)

Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study
por: Azoulay, Elie, et al.
Publicado: (2017)

Species Distribution of Candidemia and Their Susceptibility in a Single Japanese University Hospital: Prior Micafungin Use Affects the Appearance of Candida parapsilosis and Elevation of Micafungin MICs in Non-parapsilosis Candida Species
por: Sakamoto, Yasutaka, et al.
Publicado: (2021)

A case of Candida glabrata severe urinary sepsis successfully treated with micafungin
por: Pieralli, Filippo, et al.
Publicado: (2014)

Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report
por: Yamada, Shoko Merrit, et al.
Publicado: (2016)

In vitro interactions of nystatin and micafungin combined with chlorhexidine against Candida albicans isolates
por: Salehi, Maede, et al.
Publicado: (2022)

A case of breakthrough Candida parapsilosis fungemia during micafungin therapy for a Candida glabrata bloodstream infection
por: Norimatsu, Yuta, et al.
Publicado: (2017)

Epidemiological cohort study of systemic antifungal therapy for suspected or confirmed invasive candidiasis in the ICU: the Amarcand2 study
por: Constantin, J, et al.
Publicado: (2015)

Persistent candida arthritis successfully treated with micafungin instillation and surgery. A case report
por: van Egmond, Jeroen C., et al.
Publicado: (2019)

Evaluation of the synergistic antifungal activity of micafungin and voriconazole plus sertraline against Candida auris
por: Alanís-Ríos, Sergio A., et al.
Publicado: (2022)

Rapid Evolution of Multidrug Resistance in a Candida lusitaniae Infection during Micafungin Monotherapy
por: Scott, Nancy E., et al.
Publicado: (2023)

Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa
por: Kaminski, Catherine, et al.
Publicado: (2011)

Ten areas for ICU clinicians to be aware of to help retain nurses in the ICU
por: Vincent, Jean-Louis, et al.
Publicado: (2022)

Successful therapy of Candida pulcherrima fungemia in a premature newborn with liposomal amphotericin B and micafungin
por: Mpakosi, Alexandra, et al.
Publicado: (2016)

Micafungin Is an Efficient Treatment of Multi Drug-Resistant Candida glabrata Urosepsis: A Case Report
por: Javorova Rihova, Zuzana, et al.
Publicado: (2021)

A case of bloodstream co-infection of Saccharomyces cerevisiae and Candida glabrata while using micafungin
por: Furuya, Kento, et al.
Publicado: (2023)

Uniform distribution of three Candida albicans microsatellite markers in two French ICU populations supports a lack of nosocomial cross-contamination
por: Eloy, Odile, et al.
Publicado: (2006)

Pooled analysis of safety for micafungin
por: Cornely, OA, et al.
Publicado: (2008)

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
por: Wasmann, Roeland E., et al.
Publicado: (2017)

Sleepless nights in the ICU: the awaken family
por: Schmidt, Matthieu, et al.
Publicado: (2013)

Surveillance for nosocomial pathogens in our ICU
por: Kawano, Y, et al.
Publicado: (2014)

Update of the treatment of nosocomial pneumonia in the ICU
por: Zaragoza, Rafael, et al.
Publicado: (2020)

“De-escalation” strategy using micafungin for the treatment of systemic Candida infections: budget impact in France and Germany
por: van Engen, Anke, et al.
Publicado: (2017)

Candida tropicalis endocarditis successfully treated with AngioVac and micafungin followed by long-term isavuconazole suppression
por: Prabhudas-Strycker, Kirsten K., et al.
Publicado: (2020)

Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis
por: Ashizawa, Nobuyuki, et al.
Publicado: (2019)

The Fungicidal Action of Micafungin is Independent on Both Oxidative Stress Generation and HOG Pathway Signaling in Candida albicans
por: Alonso-Monge, Rebeca, et al.
Publicado: (2020)

Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation
por: Marzuttini, Francesca, et al.
Publicado: (2021)

In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four Candida auris Clades
por: Adnan, Awid, et al.
Publicado: (2023)

Topical honey: for bears, not for ICU catheters?
por: Timsit, Jean-François
Publicado: (2013)

Antifungal management in ICU: careful follow-up of voriconazole prescription needed!
por: Reizine, Florian, et al.
Publicado: (2023)

Review of the pharmacology and clinical studies of micafungin
por: Bormann, Alison M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_8krrhiasgiivn1hino1eblub7k